Medicare Enrolled
Dr. Rachel Chandler, MD
Dermatology · Midland, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chandler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandler?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chandler
Dr. Rachel Chandler is a dermatology specialist in Midland, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chandler performed 9,267 Medicare services across 4,367 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chandler received a total of $8,032 from 37 pharmaceutical and/or device companies across 425 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chandler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 10% volume in TX
$8,032 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,267
Medicare services
Top 10% in TX for dermatology
4,367
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~515 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
4,485 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,706 | $55 | $260 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,116 | $34 | $195 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
609 | $76 | $330 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
375 | $58 | $300 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
205 | $66 | $320 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
163 | $117 | $490 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $36 | $160 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
81 | $36 | $150 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
65 | $210 | $880 |
| Destruction of skin growth, 15 or more growths | 43 | $88 | $385 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
32 | $99 | $710 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
32 | $51 | $280 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $79 | $370 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
28 | $1 | $5 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
21 | $28 | $165 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
21 | $117 | $520 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
18 | $79 | $335 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
18 | $79 | $370 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
18 | $109 | $805 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
18 | $236 | $905 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
15 | $63 | $500 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
14 | $97 | $360 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
13 | $99 | $730 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
11 | $35 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
6.0% medium
93.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,032
Total received (2018-2024)
Avg $1,147/year across 7 years
Top 34% in TX for dermatology
37
Companies
425
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,720 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,329
2023
$1,554
2022
$1,543
2021
$1,248
2020
$597
2019
$1,062
2018
$699
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$977
Regeneron Healthcare Solutions, Inc.
$813
AbbVie Inc.
$654
Janssen Biotech, Inc.
$634
ABBVIE INC.
$512
Novartis Pharmaceuticals Corporation
$454
Mayne Pharma Inc.
$403
PFIZER INC.
$289
Galderma Laboratories, L.P.
$283
Allergan, Inc.
$275
E.R. Squibb & Sons, L.L.C.
$266
Nevro Corp.
$252
AbbVie, Inc.
$245
MAYNE PHARMA INC.
$217
Lilly USA, LLC
$205
LEO Pharma Inc.
$174
Sun Pharmaceutical Industries Inc.
$162
Celgene Corporation
$139
Ortho Dermatologics, a division of Bausch Health US, LLC
$131
UCB, Inc.
$107
MAYNE PHARMA COMMERCIAL LLC
$98
Incyte Corporation
$93
Arcutis Biotherapeutics, Inc.
$73
Janssen Scientific Affairs, LLC
$69
GENZYME CORPORATION
$66
Almirall LLC
$59
iCAD, Inc
$59
SUN PHARMACEUTICAL INDUSTRIES INC.
$54
Journey Medical Corporation
$45
Biofrontera Inc.
$41
Genentech USA, Inc.
$40
Kerecis Limited
$37
Lifenet Health
$33
Merck Sharp & Dohme LLC
$23
DERMIRA, INC.
$21
ORGANOGENESIS INC.
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · ARAZLO · AXXENT SURFACE CONTROLLER · Ameluz · BOTOX · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · KEYTRUDA · KLISYRI · Kerecis Omega3 SurgiClose · Klisyri · LIBTAYO · OPZELURA · ORACEA · Otezla · Puraply · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Senza Spinal Cord Stimulation System · Skyrizi · Sotyktu · TALTZ · TREMFYA · TheraGenesis Wound Matrix · Tremfya · Winlevi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $87 per 100 Medicare services performed
Geographic Context
Dermatologists within 10 mi
7
Per 100K population
4.1
County median income
$93,984
Nearest hospital
MIDLAND MEMORIAL HOSPITAL
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chandler is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chandler experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Chandler performed 4,485 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chandler receive payments from pharmaceutical companies?
Yes. Dr. Chandler received a total of $8,032 from 37 companies across 425 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chandler's costs compare to other dermatologists in Midland?
Dr. Chandler's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chandler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Midland
Browse dermatologists in Midland ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology